Cranbury, NJ, United States of America

Masano Sugiyama


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Bloomfield, NJ (US) (2014)
  • Cranbury, NJ (US) (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masano Sugiyama: Innovator in Pharmaceutical Chemistry

Introduction

Masano Sugiyama is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body. With a total of 2 patents to his name, Sugiyama's work is recognized for its potential impact on therapeutic applications.

Latest Patents

Sugiyama's latest patents include a process for the preparation of cycloheptapyridine CGRP receptor antagonists. This disclosure generally relates to a process for the preparation of compounds of formula I, including synthetic intermediates that are useful in the process. His innovative approach in this area showcases his expertise and commitment to advancing pharmaceutical science.

Career Highlights

Masano Sugiyama is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development aimed at creating new therapeutic solutions. Sugiyama's work is characterized by a focus on innovative processes that enhance the efficacy of drug compounds.

Collaborations

Throughout his career, Sugiyama has collaborated with talented professionals in the field. Notable coworkers include David Kenneth Leahy and Yu Fan, who contribute to the dynamic research environment at Bristol-Myers Squibb Company. These collaborations foster a culture of innovation and shared knowledge.

Conclusion

Masano Sugiyama's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…